Cita APA

Kubeczko, M., Cobo, S., Sánchez Bayona, R., Pycinski, B., Soberino, J., Chmielik, E., . . . Brasó-Maristany, F. (2026). Validation of the HER2DX genomic test in first-line advanced HER2-positive breast cancer treated with trastuzumab, pertuzumab, and taxane.

Citación estilo Chicago

Kubeczko, Marcin, et al. Validation of the HER2DX Genomic Test in First-line Advanced HER2-positive Breast Cancer Treated With Trastuzumab, Pertuzumab, and Taxane. 2026.

Cita MLA

Kubeczko, Marcin, et al. Validation of the HER2DX Genomic Test in First-line Advanced HER2-positive Breast Cancer Treated With Trastuzumab, Pertuzumab, and Taxane. 2026.